Neither adjunctive intravenous argatroban nor eptifibatide significantly improves ischemic stroke outcomes: Study

Stroke patients who survive a blood clot in the brain’s blood vessels are prone to developing new blockages during their recovery periods, even if they receive vessel-clearing interventions. In an effort to avoid further clots, doctors at 57 sites around the U.S. have tested a possible solution: the addition of anti-coagulant drugs to medicine that dissolves blood clots.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup